INTERNATIONAL JOURNAL OF MoleCular MEDICine 27: 429-434, 2011 Involvement of Cyr61 in the growth, invasiveness and adhesion of esophageal squamous cell carcinoma cells JIAN-JUN XIE1, LI-YAN XU2, YANG-MIN XIE3, ZE-PENG DU2, CAI-HUA FENG1, HUI-DONG1 and EN-MIN LI1 1Department of Biochemistry and Molecular Biology, 2Institute of Oncologic Pathology, The Key Immunopathology Laboratory of Guangdong Province and 3Department of Experimental Animal Center, Medical College of Shantou University, Shantou 515041, P.R. China Received October 27, 2010; Accepted December 29, 2010 DOI: 10.3892/ijmm.2011.603 Abstract. Cysteine-rich 61 (Cyr61), a secreted protein which overexpressed (Nov/CCN3), Wnt-1 induced secreted protein 1 belongs to the CCN family, has been found to be differentially (Wisp-1/CCN4), Wisp-2/CCN5, and Wisp-3/CCN6 (1,2). expressed in many cancers and to be involved in tumor Encoded by a growth factor-inducible immediate early gene, progression. The expression of Cyr61 in esophageal squamous Cyr61 is a 40 kDa protein which is extremely cysteine-rich. cell carcinoma (ESCC) has only recently been described, but This heparin-binding protein shares a 40-50% amino acid the roles of Cyr61 in ESCC cells still remained unclear. In homology with the other CCN family members. An important this study, we have shown that there are high levels of Cyr61 structural feature of CCN proteins is that they contain four in ESCC cell lines. Furthermore, using RNA interference conserved modules which exhibit similarities to the insulin-like (RNAi), we stably silenced the expression of Cyr61 in EC109 growth factor-binding proteins (IGFBPs), the von Willebrand cells, an ESCC cell line. The colony formation, MTT, cell factor type C (VWC), the thrombospondin type 1 (TSP1) and migration, cell invasiveness and cell adhesion assays were the carboxyl terminus of several extra-cellular mosaic proteins employed to address the roles of Cyr61 in the growth, migra- (CT) (3). tion and adhesion of ESCC cells. The results have shown that The CCN proteins mediate a variety of biological processes Cyr61 knockdown by RNAi leads to a significant reduction such as cell adhesion, stimulation of chemostasis, enhance- of colony formation and cell growth. The migration and ment of growth factor-induced DNA synthesis, cell survival, invasiveness ability of EC109 cells were also suppressed and angiogenesis (4-6). With respect to tumorigenesis, Cyr61 with the Cyr61 down-regulation. Furthermore, the adhesion has been shown to be involved in the development of several of the EC109 cells was decreased in the Cyr61 knockdown kinds of tumors. Cyr61 overexpression has been associated cells compared to the control cells. Taken together, our with progression and formation of larger tumors in breast data suggest that Cyr61 may play crucial roles in regulating cancer (7). Cyr61 has also been reported to stimulate the neoplasm progression of ESCC. growth of gastric adenocarcinoma (8). High expression level of Cyr61 have been found in rhabdomyosarcomas, malignant Introduction melanomas, colon adenocarcinomas, and bladder papillomas (8,9)as well as in malignant gliomas (10). Cyr61 has been Cysteine-rich 61 (Cyr61/CCN1) belongs to the Cyr61/CTGF/ reported to enhance the tumorigenicity through the integrin- Nov (CCN) protein family, which includes Cyr61/CCN1, linked kinase signaling pathway (10). However, in non-small connective tissue growth factor (CTGF/CCN2), nephroblastoma- cell lung cancer and prostate carcinoma, Cyr61 was found to be down-regulated (11,12). These findings indicate that Cyr61 has variable biological functions which are dependent on the cellular contexts. Correspondence to: Dr En-Min Li, Department of Biochemistry In human esophageal squamous cell carcinoma (ESCC), and Molecular Biology, Medical College of Shantou University, the expression of Cyr61 has only recently been described. Our Shantou 515041, P.R. China previous study has shown that Cyr61 is overexpressed in ESCC E-mail: [email protected] and that Cyr61 might be a new molecular marker to predict the prognosis of ESCC patients (13,14). Moreover, we have Dr Li-Yan Xu, Institute of Oncologic Pathology, The Key Immuno- pathology Laboratory of Guangdong Province, Medical College of also revealed that Cyr61 is involved in the fascin-mediated Shantou University, Shantou 515041, P.R. China alteration of cell proliferation and invasiveness in ESCC (15). E-mail: [email protected] However, the roles of Cyr61 in ESCC remain unclear. To investigate the role of Cyr61 in ESCC, we have used the Key words: cysteine-rich 61, esophageal squamous cell carcinoma, pSUPER RNA interference (RNAi) system to stably suppress growth, invasiveness, adhesion the expression of the Cyr61 gene in EC109, an ESCC cell line in which Cyr61 is highly expressed and we have analyzed its effects on cell growth, invasive behavior and cell adhesion. 430 xie et al: Role of Cyr61 in ESCC Cells Materials and methods number of colony-forming cells (>50 cells) was calculated under a microscope. The data were expressed as mean ± SD. Cell lines and cell culture. Human ESCC cell lines (EC109 and EC8712) and SHEE cells (a kind of immortal embryonic Chamber migration assay. Migration was evaluated using a esophageal epithelium cell line established in our laboratory) modified Boyden chamber assay. Cell culture inserts containing were maintained in Medium 199 (Invitrogen, Carlsbad, CA, polyethylene tetrephthalate were placed within a 24-well USA) containing 10% fetal calf serum (FCS) (16). The other chamber containing 0.6 ml of Medium 199 with 10% FCS. three ESCC cell lines, KYSE150, KYSE180 and KYSE510, Cells (1x105) were seeded onto the inserts suspended in 0.2 ml were maintained in DMEM medium (Invitrogen) containing of serum-free Medium 199. Non-migratory cells were removed 10% FCS. All cells were cultured in an atmosphere of 5% from the upper surface of the filter after incubation for 24 h. CO2 at 37˚C. Migrated cells were fixed and stained with Giemsa reagent. Migrating cells were quantified based on the procedure as RNAi. The mammalian expression vector, pSUPER.neo described above. circular (OligoEngine, Seattle, WA, USA), was used for small interfering RNA (siRNA) expression in EC109 cells. Briefly, Cell invasiveness assay. The invasiveness was determined by two siRNA pairs were synthesized; one pair encoded Cyr61 an invasiveness chamber assay. Cells (1x105) were seeded onto nucleotides 521-539 (siRNA1, CTGTGAATATAACTCCAGA) the top chamber of a 24-well matrigel (BD Sciences, Franklin and the second pair encoded nucleotides 513-531 (siRNA2, Lakes, NJ, USA) coated micropore membrane filter with 8-µm GGCAGACCCTGTGAATATA). The pSUPER.neo vector pores (Millipore), and the bottom chamber was filled with of the non-specific siRNA was used as a negative control 0.6 ml of Medium 199 with 10% FCS as a chemoattractant. (Vector). The siRNA expression plasmids were transfected into The membranes were fixed and stained by Giemsa reagent, EC109 cells using SuperFect reagent (Qiagen, Germantown, and the cells on the upper surface were carefully removed MD, USA) according to the manufacturer's instructions. G418 with a cotton swab after 24 h. Invasiveness was quantified by (400 µg/ml) (Calbiochem, Darmstadt, Germany) was added counting 10 random fields under a light microscope (x400). to the culture medium after 24 h. Stable G418-resistant clones Data obtained from three separate chambers are shown as were obtained in 7-9 days. The expanded cells were then used mean values. for subsequent studies. Cell adhesion assay. The cell adhesion assay was performed Western blotting. Total cell lysates were prepared in RIPA as described (19). Wells of a 96-well plate were coated at room buffer, separated by SDS-PAGE and transferred to PVDF temperature overnight with 5 µg matrigel in a final volume of membranes (Millipore, Billerica, MA, USA). The membranes 50 µl. Additional uncoated wells were incubated to serve as a were incubated in blocking buffer and then incubated with negative control. Cells were trypsinized from the dish, resus- the indicated antibody. Finally, immunoreactive bands were pended in serum-free culture medium, and 5x103 cells/100 µl revealed using luminol reagent (Santa Cruz Biotechnology, were added to each well. The plates were incubated for 15, 30, Santa Cruz, CA, USA). Photography and quantitative analyses 45 or 60 min at 37˚C. For quantification, the attached cells were performed using the FluorChem™ IS-8900 (Alpha were treated with MTT solution and absorption was measured Innotech Co., San Leandro, CA). The following antibodies at 490 nm/630 nm with an automatic ELISA reader. were used: mouse anti-Cyr61, mouse anti-β-tubulin and mouse anti-β-actin (Sigma, St. Louis, MO, USA). Statistical analysis. All data are expressed as the mean ± SD and were analyzed with the SPSS statistics software (SPSS Immunofluorescence staining. The staining procedure was 13.0 by SPSS Inc. Chicago, IL, USA). Comparisons between carried out as described (17). After being fixed with 100% data sets were performed using the χ2 test and t-test when methanol at -10˚C for 15 min, cells were incubated with appropriate. P<0.05 was considered statistically significant. blocking buffer (goat serum) for 20 min, and incubated with primary antibody overnight at 4˚C followed by incubation Results with FITC-labeled secondary antibody for 30 min at 37˚C. Finally, the nuclei were counterstained using propidium Expression of Cyr61 in ESCC cell lines. We first examined iodide (PI) (Sigma), mounted in glycerol, and viewed with a the levels of Cyr61 expression in several ESCC cell lines fluorescence microscope. and SHEE cells, an immortalized esophageal epithelial cell line by Western blotting. Cyr61 was detected in all cell Cell growth study. The MTT and colony formation assays were lines evaluated, with SHEE cells expressing the lowest level used to evaluate cell growth. The MTT test was performed as (Fig. 1A). High levels of Cyr61 were detected in EC109 cells previously described with some modifications (18).